{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T23:59:20Z","timestamp":1790553560654,"version":"4.1.0"},"reference-count":197,"publisher":"The Endocrine Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,6,1]]},"DOI":"10.1210\/er.2017-00220","type":"journal-article","created":{"date-parts":[[2018,1,26]],"date-time":"2018-01-26T19:06:52Z","timestamp":1516993612000},"page":"274-291","source":"Crossref","is-referenced-by-count":115,"title":["X-Linked Hypophosphatemia and FGF23-Related Hypophosphatemic Diseases: Prospect for New Treatment"],"prefix":"10.1210","volume":"39","author":[{"given":"Yuka","family":"Kinoshita","sequence":"first","affiliation":[{"name":"Division of Nephrology and Endocrinology, Department of Medicine, The University of Tokyo Hospital, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Fukumoto","sequence":"additional","affiliation":[{"name":"Fujii Memorial Institute of Medical Sciences, Institute of Advanced Medical Sciences, Tokushima University, Tokushima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2018,1,26]]},"reference":[{"issue":"5","key":"2019041121494138000_B1","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.tem.2009.02.001","article-title":"Bone as an endocrine organ","volume":"20","author":"Fukumoto","year":"2009","journal-title":"Trends Endocrinol Metab"},{"issue":"10","key":"2019041121494138000_B2","doi-asserted-by":"crossref","first-page":"6120","DOI":"10.1074\/jbc.C500457200","article-title":"Regulation of fibroblast growth factor-23 signaling by klotho","volume":"281","author":"Kurosu","year":"2006","journal-title":"J Biol Chem"},{"issue":"3","key":"2019041121494138000_B3","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1359\/JBMR.0301264","article-title":"FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis","volume":"19","author":"Shimada","year":"2004","journal-title":"J Bone Miner Res"},{"issue":"2","key":"2019041121494138000_B4","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/ng1095-130","article-title":"A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets","volume":"11","author":"The HYP Consortium","year":"1995","journal-title":"Nat Genet"},{"issue":"11","key":"2019041121494138000_B5","doi-asserted-by":"crossref","first-page":"6500","DOI":"10.1073\/pnas.101545198","article-title":"Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia","volume":"98","author":"Shimada","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041121494138000_B6","doi-asserted-by":"crossref","first-page":"17044","DOI":"10.1038\/nrdp.2017.44","article-title":"Tumour-induced osteomalacia","volume":"3","author":"Minisola","year":"2017","journal-title":"Nat Rev Dis Primers"},{"issue":"6","key":"2019041121494138000_B7","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/ng1358","article-title":"Mutations in GALNT3, encoding a protein involved in O-linked glycosylation, cause familial tumoral calcinosis","volume":"36","author":"Topaz","year":"2004","journal-title":"Nat Genet"},{"issue":"11","key":"2019041121494138000_B8","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.1210\/jc.2011-1239","article-title":"Iron modifies plasma FGF23 differently in autosomal dominant hypophosphatemic rickets and healthy humans","volume":"96","author":"Imel","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2019041121494138000_B9","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1210\/endo.143.8.8795","article-title":"Mutant FGF-23 responsible for autosomal dominant hypophosphatemic rickets is resistant to proteolytic cleavage and causes hypophosphatemia in vivo","volume":"143","author":"Shimada","year":"2002","journal-title":"Endocrinology"},{"issue":"15","key":"2019041121494138000_B10","doi-asserted-by":"crossref","first-page":"5520","DOI":"10.1073\/pnas.1402218111","article-title":"Dynamic regulation of FGF23 by Fam20C phosphorylation, GalNAc-T3 glycosylation, and furin proteolysis","volume":"111","author":"Tagliabracci","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"2019041121494138000_B11","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/jbmr.340","article-title":"A clinician\u2019s guide to X-linked hypophosphatemia","volume":"26","author":"Carpenter","year":"2011","journal-title":"J Bone Miner Res"},{"issue":"4","key":"2019041121494138000_B12","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1172\/JCI72829","article-title":"Randomized trial of the anti-FGF23 antibody KRN23 in X-linked hypophosphatemia","volume":"124","author":"Carpenter","year":"2014","journal-title":"J Clin Invest"},{"issue":"7","key":"2019041121494138000_B13","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1210\/jc.2015-1551","article-title":"Prolonged correction of serum phosphorus in adults with X-linked hypophosphatemia using monthly doses of KRN23","volume":"100","author":"Imel","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2019041121494138000_B14","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/jcph.611","article-title":"Population pharmacokinetic and pharmacodynamic analyses from a 4-month intradose escalation and its subsequent 12-month dose titration studies for a human monoclonal anti-FGF23 antibody (KRN23) in adults with X-linked hypophosphatemia","volume":"56","author":"Zhang","year":"2016","journal-title":"J Clin Pharmacol"},{"issue":"2","key":"2019041121494138000_B15","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00018-010-0527-z","article-title":"The emergence of phosphate as a specific signaling molecule in bone and other cell types in mammals","volume":"68","author":"Khoshniat","year":"2011","journal-title":"Cell Mol Life Sci"},{"issue":"5","key":"2019041121494138000_B16","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00431-007-0662-1","article-title":"What\u2019s new in hypophosphataemic rickets","volume":"167","author":"Pettifor","year":"2008","journal-title":"Eur J Pediatr"},{"issue":"7","key":"2019041121494138000_B17","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1002\/jcp.24312","article-title":"An integrated understanding of the physiological response to elevated extracellular phosphate","volume":"228","author":"Camalier","year":"2013","journal-title":"J Cell Physiol"},{"issue":"2","key":"2019041121494138000_B18","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1053\/j.ackd.2010.12.002","article-title":"Direct effects of phosphate on vascular cell function","volume":"18","author":"Lau","year":"2011","journal-title":"Adv Chronic Kidney Dis"},{"issue":"10","key":"2019041121494138000_B19","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/ki.2011.18","article-title":"Mitochondrial reactive oxygen species promote p65 nuclear translocation mediating high-phosphate-induced vascular calcification in vitro and in vivo","volume":"79","author":"Zhao","year":"2011","journal-title":"Kidney Int"},{"issue":"2","key":"2019041121494138000_B20","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1001\/archinte.1977.03630140051013","article-title":"The pathophysiology and clinical characteristics of severe hypophosphatemia","volume":"137","author":"Knochel","year":"1977","journal-title":"Arch Intern Med"},{"issue":"6","key":"2019041121494138000_B21","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1172\/JCI109244","article-title":"Hypophosphatemia and rhabdomyolysis","volume":"62","author":"Knochel","year":"1978","journal-title":"J Clin Invest"},{"key":"2019041121494138000_B22","volume-title":"Molecular Biology of the Cell","author":"Alberts","year":"2002","edition":"4th ed."},{"issue":"2","key":"2019041121494138000_B23","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/ki.2008.130","article-title":"Hyperphosphatemia of chronic kidney disease","volume":"74","author":"Hruska","year":"2008","journal-title":"Kidney Int"},{"issue":"2","key":"2019041121494138000_B24","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.semnephrol.2009.01.008","article-title":"The pathogenesis of vascular calcification in the chronic kidney disease mineral bone disorder: the links between bone and the vasculature","volume":"29","author":"Hruska","year":"2009","journal-title":"Semin Nephrol"},{"issue":"7","key":"2019041121494138000_B25","doi-asserted-by":"crossref","first-page":"E10","DOI":"10.1161\/01.RES.87.7.e10","article-title":"Phosphate regulation of vascular smooth muscle cell calcification","volume":"87","author":"Jono","year":"2000","journal-title":"Circ Res"},{"issue":"7","key":"2019041121494138000_B26","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1161\/01.RES.0000216409.20863.e7","article-title":"Role of the sodium-dependent phosphate cotransporter, Pit-1, in vascular smooth muscle cell calcification","volume":"98","author":"Li","year":"2006","journal-title":"Circ Res"},{"issue":"1","key":"2019041121494138000_B27","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.bone.2009.09.006","article-title":"High phosphorus diet induces vascular calcification, a related decrease in bone mass and changes in the aortic gene expression","volume":"46","author":"Rom\u00e1n-Garc\u00eda","year":"2010","journal-title":"Bone"},{"issue":"3","key":"2019041121494138000_B28","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1046\/j.1523-1755.2003.00820.x","article-title":"Uremia induces the osteoblast differentiation factor Cbfa1 in human blood vessels","volume":"63","author":"Moe","year":"2003","journal-title":"Kidney Int"},{"issue":"7","key":"2019041121494138000_B29","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.2215\/CJN.09750913","article-title":"Renal control of calcium, phosphate, and magnesium homeostasis","volume":"10","author":"Blaine","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"2019041121494138000_B30","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1177\/014860719001400190","article-title":"The refeeding syndrome: a review","volume":"14","author":"Solomon","year":"1990","journal-title":"JPEN J Parenter Enteral Nutr"},{"issue":"2","key":"2019041121494138000_B31","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1053\/j.ackd.2010.11.004","article-title":"Intestinal phosphate transport","volume":"18","author":"Sabbagh","year":"2011","journal-title":"Adv Chronic Kidney Dis"},{"issue":"5","key":"2019041121494138000_B32","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s00424-003-1072-5","article-title":"The sodium phosphate cotransporter family SLC34","volume":"447","author":"Murer","year":"2004","journal-title":"Pflugers Arch"},{"issue":"5","key":"2019041121494138000_B33","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00424-003-1088-x","article-title":"The SLC20 family of proteins: dual functions as sodium-phosphate cotransporters and viral receptors","volume":"447","author":"Collins","year":"2004","journal-title":"Pflugers Arch"},{"issue":"2","key":"2019041121494138000_B34","doi-asserted-by":"crossref","first-page":"F285","DOI":"10.1152\/ajprenal.00508.2009","article-title":"Phosphate homeostasis and the renal-gastrointestinal axis","volume":"299","author":"Marks","year":"2010","journal-title":"Am J Physiol Renal Physiol"},{"issue":"1","key":"2019041121494138000_B35","doi-asserted-by":"crossref","first-page":"C159","DOI":"10.1152\/ajpcell.00456.2004","article-title":"Parathyroid hormone treatment induces dissociation of type IIa Na+-P(i) cotransporter-Na+\/H+ exchanger regulatory factor-1 complexes","volume":"289","author":"D\u00e9liot","year":"2005","journal-title":"Am J Physiol Cell Physiol"},{"issue":"5 Pt 2","key":"2019041121494138000_B36","first-page":"F900","article-title":"Cellular mechanisms of acute and chronic adaptation of rat renal P(i) transporter to alterations in dietary P(i)","volume":"267","author":"Levi","year":"1994","journal-title":"Am J Physiol"},{"issue":"1","key":"2019041121494138000_B37","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/oxfordjournals.jbchem.a021569","article-title":"Acute regulation by dietary phosphate of the sodium-dependent phosphate transporter (NaP(i)-2) in rat kidney","volume":"121","author":"Katai","year":"1997","journal-title":"J Biochem"},{"issue":"3","key":"2019041121494138000_B38","doi-asserted-by":"crossref","first-page":"F587","DOI":"10.1152\/ajprenal.00097.2004","article-title":"Internalization of renal type IIc Na-Pi cotransporter in response to a high-phosphate diet","volume":"288","author":"Segawa","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"issue":"2","key":"2019041121494138000_B39","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00424-008-0530-5","article-title":"Renal phosphaturia during metabolic acidosis revisited: molecular mechanisms for decreased renal phosphate reabsorption","volume":"457","author":"Nowik","year":"2008","journal-title":"Pflugers Arch"},{"issue":"1","key":"2019041121494138000_B40","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1172\/JCI118022","article-title":"Dexamethasone modulates rat renal brush border membrane phosphate transporter mRNA and protein abundance and glycosphingolipid composition","volume":"96","author":"Levi","year":"1995","journal-title":"J Clin Invest"},{"issue":"1","key":"2019041121494138000_B41","first-page":"7","article-title":"Paracellular phosphate absorption in rat colon: a mechanism for enema-induced hyperphosphatemia","volume":"23","author":"Hu","year":"1997","journal-title":"Miner Electrolyte Metab"},{"issue":"4","key":"2019041121494138000_B42","doi-asserted-by":"crossref","first-page":"G355","DOI":"10.1152\/ajpgi.00244.2016","article-title":"Intestinal phosphate absorption is mediated by multiple transport systems in rats","volume":"312","author":"Candeal","year":"2017","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"3","key":"2019041121494138000_B43","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1113\/expphysiol.2005.032516","article-title":"Intestinal phosphate absorption and the effect of vitamin D: a comparison of rats with mice","volume":"91","author":"Marks","year":"2006","journal-title":"Exp Physiol"},{"issue":"5","key":"2019041121494138000_B44","doi-asserted-by":"crossref","first-page":"F1466","DOI":"10.1152\/ajprenal.00279.2009","article-title":"Regulation of rat intestinal Na-dependent phosphate transporters by dietary phosphate","volume":"297","author":"Giral","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"issue":"Pt 3","key":"2019041121494138000_B45","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1042\/bj3430705","article-title":"Regulation of intestinal Na+-dependent phosphate co-transporters by a low-phosphate diet and 1,25-dihydroxyvitamin D3","volume":"343","author":"Katai","year":"1999","journal-title":"Biochem J"},{"issue":"2","key":"2019041121494138000_B46","doi-asserted-by":"crossref","first-page":"C429","DOI":"10.1152\/ajpcell.00331.2004","article-title":"Intestinal and renal adaptation to a low-Pi diet of type II NaPi cotransporters in vitamin D receptor- and 1alphaOHase-deficient mice","volume":"288","author":"Capuano","year":"2005","journal-title":"Am J Physiol Cell Physiol"},{"issue":"8054","key":"2019041121494138000_B47","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(78)90358-6","article-title":"Osteomalacia after small-intestinal resection","volume":"1","author":"Compston","year":"1978","journal-title":"Lancet"},{"key":"2019041121494138000_B48","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.bone.2017.02.003","article-title":"Unexpected widespread hypophosphatemia and bone disease associated with elemental formula use in infants and children","volume":"97","author":"Gonzalez Ballesteros","year":"2017","journal-title":"Bone"},{"issue":"2","key":"2019041121494138000_B49","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1086\/499409","article-title":"SLC34A3 mutations in patients with hereditary hypophosphatemic rickets with hypercalciuria predict a key role for the sodium-phosphate cotransporter NaPi-IIc in maintaining phosphate homeostasis","volume":"78","author":"Bergwitz","year":"2006","journal-title":"Am J Hum Genet"},{"issue":"2","key":"2019041121494138000_B50","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1086\/427887","article-title":"Dent Disease with mutations in OCRL1","volume":"76","author":"Hoopes","year":"2005","journal-title":"Am J Hum Genet"},{"issue":"6564","key":"2019041121494138000_B51","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/379445a0","article-title":"A common molecular basis for three inherited kidney stone diseases","volume":"379","author":"Lloyd","year":"1996","journal-title":"Nature"},{"issue":"6383","key":"2019041121494138000_B52","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/358239a0","article-title":"The Lowe\u2019s oculocerebrorenal syndrome gene encodes a protein highly homologous to inositol polyphosphate-5-phosphatase","volume":"358","author":"Attree","year":"1992","journal-title":"Nature"},{"issue":"4","key":"2019041121494138000_B53","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/qjmed\/hct258","article-title":"Drug-induced renal Fanconi syndrome","volume":"107","author":"Hall","year":"2014","journal-title":"QJM"},{"issue":"12","key":"2019041121494138000_B54","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.2215\/CJN.02560316","article-title":"Paraprotein-related kidney disease: kidney injury from paraproteins-what determines the site of injury","volume":"11","author":"Doshi","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"2019041121494138000_B55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00441-010-1024-2","article-title":"Hormone-like (endocrine) Fgfs: their evolutionary history and roles in development, metabolism, and disease","volume":"342","author":"Itoh","year":"2010","journal-title":"Cell Tissue Res"},{"issue":"3","key":"2019041121494138000_B56","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/81664","article-title":"Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23","volume":"26","author":"ADHR Consortium","year":"2000","journal-title":"Nat Genet"},{"issue":"1","key":"2019041121494138000_B57","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1073\/pnas.0902006107","article-title":"Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation","volume":"107","author":"Goetz","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"2019041121494138000_B58","doi-asserted-by":"crossref","first-page":"G1036","DOI":"10.1152\/ajpgi.00243.2005","article-title":"1alpha,25-Dihydroxyvitamin D3 upregulates FGF23 gene expression in bone: the final link in a renal-gastrointestinal-skeletal axis that controls phosphate transport","volume":"289","author":"Kolek","year":"2005","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"3","key":"2019041121494138000_B59","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1677\/JOE-10-0058","article-title":"1alpha,25-Dihydroxyvitamin D3 acts predominately in mature osteoblasts under conditions of high extracellular phosphate to increase fibroblast growth factor 23 production in vitro","volume":"206","author":"Yamamoto","year":"2010","journal-title":"J Endocrinol"},{"issue":"6","key":"2019041121494138000_B60","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1210\/er.2008-0004","article-title":"Vitamin D and human health: lessons from vitamin D receptor null mice","volume":"29","author":"Bouillon","year":"2008","journal-title":"Endocr Rev"},{"issue":"6","key":"2019041121494138000_B61","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1507\/endocrj.EJ16-0583","article-title":"Changes in bone metabolic parameters following oral calcium supplementation in an adult patient with vitamin D-dependent rickets type 2A","volume":"64","author":"Kinoshita","year":"2017","journal-title":"Endocr J"},{"issue":"6","key":"2019041121494138000_B62","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1093\/ndt\/gfr668","article-title":"Changes in fibroblast growth factor 23 during treatment of secondary hyperparathyroidism with alfacalcidol or paricalcitol","volume":"27","author":"Hansen","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"2019041121494138000_B63","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.2215\/CJN.03270314","article-title":"Effect of cinacalcet and vitamin D analogs on fibroblast growth factor-23 during the treatment of secondary hyperparathyroidism","volume":"10","author":"Sprague","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"2019041121494138000_B64","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s00774-015-0651-9","article-title":"Phosphate enhances Fgf23 expression through reactive oxygen species in UMR-106 cells","volume":"34","author":"Hori","year":"2016","journal-title":"J Bone Miner Metab"},{"issue":"12","key":"2019041121494138000_B65","doi-asserted-by":"crossref","first-page":"5358","DOI":"10.1210\/en.2005-0777","article-title":"Dietary and serum phosphorus regulate fibroblast growth factor 23 expression and 1,25-dihydroxyvitamin D metabolism in mice","volume":"146","author":"Perwad","year":"2005","journal-title":"Endocrinology"},{"issue":"8","key":"2019041121494138000_B66","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1210\/jc.2006-0021","article-title":"Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men","volume":"91","author":"Antoniucci","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2019041121494138000_B67","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1210\/jc.2004-1039","article-title":"Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men","volume":"90","author":"Ferrari","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2019041121494138000_B68","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00774-007-0779-3","article-title":"Effect of acute changes of serum phosphate on fibroblast growth factor (FGF)23 levels in humans","volume":"25","author":"Ito","year":"2007","journal-title":"J Bone Miner Metab"},{"issue":"46","key":"2019041121494138000_B69","doi-asserted-by":"crossref","first-page":"E1146","DOI":"10.1073\/pnas.1110905108","article-title":"Iron deficiency drives an autosomal dominant hypophosphatemic rickets (ADHR) phenotype in fibroblast growth factor-23 (Fgf23) knock-in mice","volume":"108","author":"Farrow","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"2019041121494138000_B70","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1002\/jbmr.1923","article-title":"Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women","volume":"28","author":"Wolf","year":"2013","journal-title":"J Bone Miner Res"},{"issue":"11","key":"2019041121494138000_B71","doi-asserted-by":"crossref","first-page":"e427","DOI":"10.3324\/haematol.2017.167882","article-title":"Erythropoietin stimulates murine and human fibroblast growth factor-23, revealing novel roles for bone and bone marrow","volume":"102","author":"Clinkenbeard","year":"2017","journal-title":"Haematologica"},{"issue":"4","key":"2019041121494138000_B72","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.bone.2009.06.017","article-title":"Hypophosphatemia induced by intravenous administration of saccharated ferric oxide: another form of FGF23-related hypophosphatemia","volume":"45","author":"Shimizu","year":"2009","journal-title":"Bone"},{"issue":"2","key":"2019041121494138000_B73","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/jbmr.2049","article-title":"Neonatal iron deficiency causes abnormal phosphate metabolism by elevating FGF23 in normal and ADHR mice","volume":"29","author":"Clinkenbeard","year":"2014","journal-title":"J Bone Miner Res"},{"issue":"7","key":"2019041121494138000_B74","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1210\/jc.2008-2396","article-title":"FGF23 elevation and hypophosphatemia after intravenous iron polymaltose: a prospective study","volume":"94","author":"Schouten","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2019041121494138000_B75","doi-asserted-by":"crossref","first-page":"e0167146","DOI":"10.1371\/journal.pone.0167146","article-title":"Choice of high-dose intravenous iron preparation determines hypophosphatemia risk","volume":"11","author":"Schaefer","year":"2016","journal-title":"PLoS One"},{"issue":"29","key":"2019041121494138000_B76","doi-asserted-by":"crossref","first-page":"17006","DOI":"10.1074\/jbc.271.29.17006","article-title":"cDNA cloning and expression of a novel human UDP-N-acetyl-alpha-D-galactosamine. Polypeptide N-acetylgalactosaminyltransferase, GalNAc-t3","volume":"271","author":"Bennett","year":"1996","journal-title":"J Biol Chem"},{"issue":"2","key":"2019041121494138000_B77","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1359\/jbmr.061105","article-title":"Hyperostosis-hyperphosphatemia syndrome: a congenital disorder of O-glycosylation associated with augmented processing of fibroblast growth factor 23","volume":"22","author":"Frishberg","year":"2007","journal-title":"J Bone Miner Res"},{"issue":"6","key":"2019041121494138000_B78","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1038\/ki.2014.215","article-title":"Parathyroid hormone activates the orphan nuclear receptor Nurr1 to induce FGF23 transcription","volume":"86","author":"Meir","year":"2014","journal-title":"Kidney Int"},{"issue":"5","key":"2019041121494138000_B79","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1210\/en.2016-1451","article-title":"Acute parathyroid hormone injection increases C-terminal but not intact fibroblast growth factor 23 levels","volume":"158","author":"Knab","year":"2017","journal-title":"Endocrinology"},{"issue":"1","key":"2019041121494138000_B80","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1096\/fj.15-278184","article-title":"Parathyroid hormone 1 receptor is essential to induce FGF23 production and maintain systemic mineral ion homeostasis","volume":"30","author":"Fan","year":"2016","journal-title":"FASEB J"},{"issue":"11","key":"2019041121494138000_B81","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1210\/jc.2002-021105","article-title":"Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets\/osteomalacia","volume":"87","author":"Yamazaki","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2019041121494138000_B82","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.bone.2008.02.014","article-title":"Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23) in hypophosphatemic patients: proposal of diagnostic criteria using FGF23 measurement","volume":"42","author":"Endo","year":"2008","journal-title":"Bone"},{"issue":"12","key":"2019041121494138000_B83","first-page":"4003","article-title":"The parathyroid is a target organ for FGF23 in rats","volume":"117","author":"Ben-Dov","year":"2007","journal-title":"J Clin Invest"},{"issue":"12","key":"2019041121494138000_B84","doi-asserted-by":"crossref","first-page":"e1003975","DOI":"10.1371\/journal.pgen.1003975","article-title":"Parathyroid-specific deletion of Klotho unravels a novel calcineurin-dependent FGF23 signaling pathway that regulates PTH secretion","volume":"9","author":"Olauson","year":"2013","journal-title":"PLoS Genet"},{"key":"2019041121494138000_B85","doi-asserted-by":"crossref","first-page":"40534","DOI":"10.1038\/srep40534","article-title":"Persistent fibroblast growth factor 23 signalling in the parathyroid glands for secondary hyperparathyroidism in mice with chronic kidney disease","volume":"7","author":"Kawakami","year":"2017","journal-title":"Sci Rep"},{"issue":"11","key":"2019041121494138000_B86","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy","volume":"121","author":"Faul","year":"2011","journal-title":"J Clin Invest"},{"issue":"3","key":"2019041121494138000_B87","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1053\/j.jrn.2013.01.024","article-title":"Fibroblast growth factor 23, Klotho, and disordered mineral metabolism in chronic kidney disease: unraveling the intricate tapestry of events and implications for therapy","volume":"23","author":"Guti\u00e9rrez","year":"2013","journal-title":"J Ren Nutr"},{"issue":"1","key":"2019041121494138000_B88","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/ki.2012.327","article-title":"Higher fibroblast growth factor-23 increases the risk of all-cause and cardiovascular mortality in the community","volume":"83","author":"\u00c4rnl\u00f6v","year":"2013","journal-title":"Kidney Int"},{"issue":"6","key":"2019041121494138000_B89","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.cmet.2015.09.002","article-title":"Activation of cardiac fibroblast growth factor receptor 4 causes left ventricular hypertrophy","volume":"22","author":"Grabner","year":"2015","journal-title":"Cell Metab"},{"issue":"9","key":"2019041121494138000_B90","doi-asserted-by":"crossref","first-page":"e44161","DOI":"10.1371\/journal.pone.0044161","article-title":"A comparative transcriptome analysis identifying FGF23 regulated genes in the kidney of a mouse CKD model","volume":"7","author":"Dai","year":"2012","journal-title":"PLoS One"},{"issue":"5","key":"2019041121494138000_B91","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/jbmr.5650050508","article-title":"Normal left ventricular performance in children with X-linked hypophosphatemic rickets: a Doppler echocardiography study","volume":"5","author":"Vered","year":"1990","journal-title":"J Bone Miner Res"},{"issue":"2","key":"2019041121494138000_B92","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1080\/07435800.2016.1242604","article-title":"Patients with FGF23-related hypophosphatemic rickets\/osteomalacia do not present with left ventricular hypertrophy","volume":"42","author":"Takashi","year":"2017","journal-title":"Endocr Res"},{"key":"2019041121494138000_B93","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.bone.2016.11.012","article-title":"Vascular calcification in CKD-MBD: roles for phosphate, FGF23, and Klotho","volume":"100","author":"Yamada","year":"2017","journal-title":"Bone"},{"issue":"5","key":"2019041121494138000_B94","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/ki.2013.332","article-title":"Fibroblast growth factor 23 accelerates phosphate-induced vascular calcification in the absence of Klotho deficiency","volume":"85","author":"Jimbo","year":"2014","journal-title":"Kidney Int"},{"issue":"6","key":"2019041121494138000_B95","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/ki.2013.3","article-title":"Fibroblast growth factor 23 is not associated with and does not induce arterial calcification","volume":"83","author":"Scialla","year":"2013","journal-title":"Kidney Int"},{"issue":"4","key":"2019041121494138000_B96","doi-asserted-by":"crossref","first-page":"e60658","DOI":"10.1371\/journal.pone.0060658","article-title":"Arterial klotho expression and FGF23 effects on vascular calcification and function","volume":"8","author":"Lindberg","year":"2013","journal-title":"PLoS One"},{"issue":"18","key":"2019041121494138000_B97","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1161\/CIRCULATIONAHA.111.053405","article-title":"Vascular Klotho deficiency potentiates the development of human artery calcification and mediates resistance to fibroblast growth factor 23","volume":"125","author":"Lim","year":"2012","journal-title":"Circulation"},{"issue":"1-2","key":"2019041121494138000_B98","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mce.2013.03.008","article-title":"A protective role for FGF-23 in local defence against disrupted arterial wall integrity","volume":"372","author":"Zhu","year":"2013","journal-title":"Mol Cell Endocrinol"},{"issue":"2","key":"2019041121494138000_B99","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.cytogfr.2005.01.001","article-title":"Cellular signaling by fibroblast growth factor receptors","volume":"16","author":"Eswarakumar","year":"2005","journal-title":"Cytokine Growth Factor Rev"},{"issue":"7120","key":"2019041121494138000_B100","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/nature05315","article-title":"Klotho converts canonical FGF receptor into a specific receptor for FGF23","volume":"444","author":"Urakawa","year":"2006","journal-title":"Nature"},{"issue":"2","key":"2019041121494138000_B101","doi-asserted-by":"crossref","first-page":"F282","DOI":"10.1152\/ajprenal.90742.2008","article-title":"FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1","volume":"297","author":"Gattineni","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"issue":"2","key":"2019041121494138000_B102","doi-asserted-by":"crossref","first-page":"F371","DOI":"10.1152\/ajprenal.00740.2010","article-title":"Regulation of serum 1,25(OH)2 vitamin D3 levels by fibroblast growth factor 23 is mediated by FGF receptors 3 and 4","volume":"301","author":"Gattineni","year":"2011","journal-title":"Am J Physiol Renal Physiol"},{"issue":"12","key":"2019041121494138000_B103","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1681\/ASN.2007121301","article-title":"FGFR3 and FGFR4 do not mediate renal effects of FGF23","volume":"19","author":"Liu","year":"2008","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"2019041121494138000_B104","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.kint.2016.05.019","article-title":"Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease","volume":"90","author":"Singh","year":"2016","journal-title":"Kidney Int"},{"issue":"3","key":"2019041121494138000_B105","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1006\/bbrc.1997.8019","article-title":"Identification of the human klotho gene and its two transcripts encoding membrane and secreted klotho protein","volume":"242","author":"Matsumura","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"issue":"6655","key":"2019041121494138000_B106","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/36285","article-title":"Mutation of the mouse klotho gene leads to a syndrome resembling ageing","volume":"390","author":"Kuro-o","year":"1997","journal-title":"Nature"},{"issue":"10","key":"2019041121494138000_B107","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1002\/jbmr.3195","article-title":"Klotho lacks an FGF23-independent role in mineral homeostasis","volume":"32","author":"Andrukhova","year":"2017","journal-title":"J Bone Miner Res"},{"issue":"9","key":"2019041121494138000_B108","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.1096\/fj.10-154765","article-title":"Klotho: a novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule","volume":"24","author":"Hu","year":"2010","journal-title":"FASEB J"},{"issue":"10","key":"2019041121494138000_B109","doi-asserted-by":"crossref","first-page":"E1308","DOI":"10.1210\/jc.2015-1800","article-title":"\u03b1-Klotho expression in human tissues","volume":"100","author":"Lim","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2019041121494138000_B110","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1681\/ASN.2013111209","article-title":"The kidney is the principal organ mediating klotho effects","volume":"25","author":"Lindberg","year":"2014","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"2019041121494138000_B111","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.kint.2016.04.009","article-title":"In\u00a0vivo evidence for a limited role of proximal tubular Klotho in renal phosphate handling","volume":"90","author":"Ide","year":"2016","journal-title":"Kidney Int"},{"issue":"10","key":"2019041121494138000_B112","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1681\/ASN.2012010048","article-title":"Targeted deletion of Klotho in kidney distal tubule disrupts mineral metabolism","volume":"23","author":"Olauson","year":"2012","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"2019041121494138000_B113","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.bone.2012.05.015","article-title":"FGF23 acts directly on renal proximal tubules to induce phosphaturia through activation of the ERK1\/2-SGK1 signaling pathway","volume":"51","author":"Andrukhova","year":"2012","journal-title":"Bone"},{"issue":"3","key":"2019041121494138000_B114","first-page":"229","article-title":"FGF23 promotes renal calcium reabsorption through the TRPV5 channel","volume":"33","author":"Andrukhova","year":"2014","journal-title":"EMBO J"},{"issue":"9","key":"2019041121494138000_B115","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1111\/j.1532-5415.2011.03558.x","article-title":"Plasma klotho and cardiovascular disease in adults","volume":"59","author":"Semba","year":"2011","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"2019041121494138000_B116","doi-asserted-by":"crossref","first-page":"e56695","DOI":"10.1371\/journal.pone.0056695","article-title":"A decreased level of serum soluble Klotho is an independent biomarker associated with arterial stiffness in patients with chronic kidney disease","volume":"8","author":"Kitagawa","year":"2013","journal-title":"PLoS One"},{"issue":"9","key":"2019041121494138000_B117","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1073\/pnas.0712361105","article-title":"A translocation causing increased alpha-klotho level results in hypophosphatemic rickets and hyperparathyroidism","volume":"105","author":"Brownstein","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"2019041121494138000_B118","doi-asserted-by":"crossref","first-page":"4710","DOI":"10.1172\/JCI64986","article-title":"Circulating \u03b1Klotho influences phosphate handling by controlling FGF23 production","volume":"122","author":"Smith","year":"2012","journal-title":"J Clin Invest"},{"issue":"11","key":"2019041121494138000_B119","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/ng1868","article-title":"DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone matrix protein in the regulation of phosphate homeostasis","volume":"38","author":"Lorenz-Depiereux","year":"2006","journal-title":"Nat Genet"},{"issue":"2","key":"2019041121494138000_B120","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ajhg.2010.01.010","article-title":"Autosomal-recessive hypophosphatemic rickets is associated with an inactivation mutation in the ENPP1 gene","volume":"86","author":"Levy-Litan","year":"2010","journal-title":"Am J Hum Genet"},{"issue":"2","key":"2019041121494138000_B121","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ajhg.2010.01.006","article-title":"Loss-of-function ENPP1 mutations cause both generalized arterial calcification of infancy and autosomal-recessive hypophosphatemic rickets","volume":"86","author":"Lorenz-Depiereux","year":"2010","journal-title":"Am J Hum Genet"},{"issue":"11","key":"2019041121494138000_B122","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/ng1905","article-title":"Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism","volume":"38","author":"Feng","year":"2006","journal-title":"Nat Genet"},{"issue":"4","key":"2019041121494138000_B123","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1359\/jbmr.070107","article-title":"FGF23 concentrations vary with disease status in autosomal dominant hypophosphatemic rickets","volume":"22","author":"Imel","year":"2007","journal-title":"J Bone Miner Res"},{"issue":"17","key":"2019041121494138000_B124","doi-asserted-by":"crossref","first-page":"12624","DOI":"10.1016\/S0021-9258(18)31434-0","article-title":"Characterization of a novel dentin matrix acidic phosphoprotein. Implications for induction of biomineralization","volume":"268","author":"George","year":"1993","journal-title":"J Biol Chem"},{"key":"2019041121494138000_B125","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.bone.2014.08.014","article-title":"Exome sequencing reveals a mutation in DMP1 in a family with familial sclerosing bone dysplasia","volume":"68","author":"Gannag\u00e9-Yared","year":"2014","journal-title":"Bone"},{"issue":"3","key":"2019041121494138000_B126","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s11302-012-9309-4","article-title":"Cellular function and molecular structure of ecto-nucleotidases","volume":"8","author":"Zimmermann","year":"2012","journal-title":"Purinergic Signal"},{"issue":"3","key":"2019041121494138000_B127","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/956","article-title":"Mutation in Npps in a mouse model of ossification of the posterior longitudinal ligament of the spine","volume":"19","author":"Okawa","year":"1998","journal-title":"Nat Genet"},{"issue":"4","key":"2019041121494138000_B128","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/ng1221","article-title":"Mutations in ENPP1 are associated with \u2018idiopathic\u2019 infantile arterial calcification","volume":"34","author":"Rutsch","year":"2003","journal-title":"Nat Genet"},{"issue":"14","key":"2019041121494138000_B129","doi-asserted-by":"crossref","first-page":"9445","DOI":"10.1073\/pnas.142063399","article-title":"Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization","volume":"99","author":"Hessle","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041121494138000_B130","doi-asserted-by":"crossref","unstructured":"Hiratsuka S , TakahataM, ShimizuT, HamanoH, OtaM, SatoD, IwasakiN. Drug therapy targeting pyrophosphate slows the ossification of spinal ligaments in twy mice [published online ahead of print September 20, 2017]. J Orthop Res.","DOI":"10.1002\/jor.23743"},{"issue":"1","key":"2019041121494138000_B131","doi-asserted-by":"crossref","first-page":"7786","DOI":"10.1038\/s41598-017-07341-2","article-title":"Enpp1 is an anti-aging factor that regulates Klotho under phosphate overload conditions","volume":"7","author":"Watanabe","year":"2017","journal-title":"Sci Rep"},{"issue":"6","key":"2019041121494138000_B132","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1002\/jbmr.1850","article-title":"Exome sequencing reveals FAM20c mutations associated with fibroblast growth factor 23-related hypophosphatemia, dental anomalies, and ectopic calcification","volume":"28","author":"Rafaelsen","year":"2013","journal-title":"J Bone Miner Res"},{"key":"2019041121494138000_B133","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.bone.2014.06.026","article-title":"Hypophosphatemic osteomalacia and bone sclerosis caused by a novel homozygous mutation of the FAM20C gene in an elderly man with a mild variant of Raine syndrome","volume":"67","author":"Takeyari","year":"2014","journal-title":"Bone"},{"issue":"3","key":"2019041121494138000_B134","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1399-0004.2008.01118.x","article-title":"Mutations in FAM20C also identified in non-lethal osteosclerotic bone dysplasia","volume":"75","author":"Simpson","year":"2009","journal-title":"Clin Genet"},{"issue":"2","key":"2019041121494138000_B135","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1399-0004.2010.01516.x","article-title":"Osteosclerotic bone dysplasia in siblings with a Fam20C mutation","volume":"80","author":"Fradin","year":"2011","journal-title":"Clin Genet"},{"issue":"1","key":"2019041121494138000_B136","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1471-2164-6-11","article-title":"FAM20: an evolutionarily conserved family of secreted proteins expressed in hematopoietic cells","volume":"6","author":"Nalbant","year":"2005","journal-title":"BMC Genomics"},{"issue":"11","key":"2019041121494138000_B137","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1369\/jhc.2010.956565","article-title":"Expression of FAM20C in the osteogenesis and odontogenesis of mouse","volume":"58","author":"Wang","year":"2010","journal-title":"J Histochem Cytochem"},{"issue":"7","key":"2019041121494138000_B138","doi-asserted-by":"crossref","first-page":"4060","DOI":"10.1073\/pnas.0638023100","article-title":"Mineralized tissue and vertebrate evolution: the secretory calcium-binding phosphoprotein gene cluster","volume":"100","author":"Kawasaki","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6085","key":"2019041121494138000_B139","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1126\/science.1217817","article-title":"Secreted kinase phosphorylates extracellular proteins that regulate biomineralization","volume":"336","author":"Tagliabracci","year":"2012","journal-title":"Science"},{"issue":"8","key":"2019041121494138000_B140","doi-asserted-by":"crossref","first-page":"e42988","DOI":"10.1371\/journal.pone.0042988","article-title":"The Raine syndrome protein FAM20C is a Golgi kinase that phosphorylates bio-mineralization proteins","volume":"7","author":"Ishikawa","year":"2012","journal-title":"PLoS One"},{"issue":"5","key":"2019041121494138000_B141","doi-asserted-by":"crossref","first-page":"e1002708","DOI":"10.1371\/journal.pgen.1002708","article-title":"Inactivation of a novel FGF23 regulator, FAM20C, leads to hypophosphatemic rickets in mice","volume":"8","author":"Wang","year":"2012","journal-title":"PLoS Genet"},{"issue":"2","key":"2019041121494138000_B142","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1086\/427956","article-title":"Mutations that cause osteoglophonic dysplasia define novel roles for FGFR1 in bone elongation","volume":"76","author":"White","year":"2005","journal-title":"Am J Hum Genet"},{"issue":"1","key":"2019041121494138000_B143","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1210\/jc.2008-0220","article-title":"Hypophosphatemia with elevations in serum fibroblast growth factor 23 in a child with Jansen\u2019s metaphyseal chondrodysplasia","volume":"94","author":"Brown","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2019041121494138000_B144","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1172\/JCI18399","article-title":"FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting","volume":"112","author":"Riminucci","year":"2003","journal-title":"J Clin Invest"},{"issue":"1","key":"2019041121494138000_B145","doi-asserted-by":"crossref","first-page":"E132","DOI":"10.1210\/jc.2013-2813","article-title":"Postzygotic HRAS mutation causing both keratinocytic epidermal nevus and thymoma and associated with bone dysplasia and hypophosphatemia due to elevated FGF23","volume":"99","author":"Avitan-Hersh","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2019041121494138000_B146","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/hmg\/ddt429","article-title":"Multilineage somatic activating mutations in HRAS and NRAS cause mosaic cutaneous and skeletal lesions, elevated FGF23 and hypophosphatemia","volume":"23","author":"Lim","year":"2014","journal-title":"Hum Mol Genet"},{"issue":"3","key":"2019041121494138000_B147","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S8756-3282(00)00334-3","article-title":"Tumor-induced osteomalacia and the regulation of phosphate homeostasis","volume":"27","author":"Kumar","year":"2000","journal-title":"Bone"},{"issue":"Pt 2","key":"2019041121494138000_B148","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1258\/acb.2008.008151","article-title":"Iron polymaltose-induced FGF23 elevation complicated by hypophosphataemic osteomalacia","volume":"46","author":"Schouten","year":"2009","journal-title":"Ann Clin Biochem"},{"issue":"1","key":"2019041121494138000_B149","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s100240050008","article-title":"Phosphaturic mesenchymal tumor-induced rickets","volume":"3","author":"Reyes-M\u00fagica","year":"2000","journal-title":"Pediatr Dev Pathol"},{"issue":"6","key":"2019041121494138000_B150","doi-asserted-by":"crossref","first-page":"e1518","DOI":"10.1542\/peds.2014-2218","article-title":"Tumor-induced rickets in a child with a central giant cell granuloma: a case report","volume":"135","author":"Fern\u00e1ndez-Cooke","year":"2015","journal-title":"Pediatrics"},{"issue":"1","key":"2019041121494138000_B151","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/BPB.0b013e32832f59cb","article-title":"A 9-month-old phosphaturic mesenchymal tumor mimicking the intractable rickets","volume":"19","author":"Jung","year":"2010","journal-title":"J Pediatr Orthop B"},{"issue":"3","key":"2019041121494138000_B152","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1530\/ERC-11-0006","article-title":"Tumor-induced osteomalacia","volume":"18","author":"Chong","year":"2011","journal-title":"Endocr Relat Cancer"},{"issue":"4","key":"2019041121494138000_B153","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/j.1365-2796.2010.02262.x","article-title":"Clinical utility of systemic venous sampling of FGF23 for identifying tumours responsible for tumour-induced osteomalacia","volume":"268","author":"Ito","year":"2010","journal-title":"J Intern Med"},{"issue":"12","key":"2019041121494138000_B154","doi-asserted-by":"crossref","first-page":"4403","DOI":"10.1210\/jc.2014-2120","article-title":"Ovarian cancer-related hypophosphatemic osteomalacia--a case report","volume":"99","author":"Lin","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2019041121494138000_B155","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1210\/jc.2012-3473","article-title":"Oncogenic osteomalacia due to FGF23-expressing colon adenocarcinoma","volume":"98","author":"Leaf","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2019041121494138000_B156","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1007\/s00520-012-1474-z","article-title":"Advanced prostate cancer as a cause of oncogenic osteomalacia: an underdiagnosed condition","volume":"20","author":"Mak","year":"2012","journal-title":"Support Care Cancer"},{"issue":"8","key":"2019041121494138000_B157","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1210\/jc.2004-0406","article-title":"Venous sampling for fibroblast growth factor-23 confirms preoperative diagnosis of tumor-induced osteomalacia","volume":"89","author":"Takeuchi","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2019041121494138000_B158","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1002\/jbmr.316","article-title":"Selective venous catheterization for the localization of phosphaturic mesenchymal tumors","volume":"26","author":"Andreopoulou","year":"2011","journal-title":"J Bone Miner Res"},{"issue":"10","key":"2019041121494138000_B159","doi-asserted-by":"crossref","first-page":"5523","DOI":"10.1210\/jc.2005-0301","article-title":"A novel mutation in fibroblast growth factor 23 gene as a cause of tumoral calcinosis","volume":"90","author":"Araya","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2019041121494138000_B160","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1172\/JCI31330","article-title":"A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis","volume":"117","author":"Ichikawa","year":"2007","journal-title":"J Clin Invest"},{"issue":"3","key":"2019041121494138000_B161","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/hmg\/ddi034","article-title":"An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia","volume":"14","author":"Benet-Pag\u00e8s","year":"2005","journal-title":"Hum Mol Genet"},{"issue":"4","key":"2019041121494138000_B162","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1172\/JCI200419081","article-title":"Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism","volume":"113","author":"Shimada","year":"2004","journal-title":"J Clin Invest"},{"issue":"2","key":"2019041121494138000_B163","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0031-3955(05)70485-5","article-title":"New perspectives on the biology and treatment of X-linked hypophosphatemic rickets","volume":"44","author":"Carpenter","year":"1997","journal-title":"Pediatr Clin North Am"},{"issue":"6","key":"2019041121494138000_B164","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1101\/gr.7.6.573","article-title":"Genomic organization of the human PEX gene mutated in X-linked dominant hypophosphatemic rickets","volume":"7","author":"Francis","year":"1997","journal-title":"Genome Res"},{"issue":"6","key":"2019041121494138000_B165","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1172\/JCI119276","article-title":"Pex\/PEX tissue distribution and evidence for a deletion in the 3\u2032 region of the Pex gene in X-linked hypophosphatemic mice","volume":"99","author":"Beck","year":"1997","journal-title":"J Clin Invest"},{"key":"2019041121494138000_B166","first-page":"37419","article-title":"Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX","volume-title":"J Biol Chem","author":"Liu","year":"2003"},{"issue":"2","key":"2019041121494138000_B167","first-page":"722","article-title":"Aberrant Phex function in osteoblasts and osteocytes alone underlies murine X-linked hypophosphatemia","volume":"118","author":"Yuan","year":"2008","journal-title":"J Clin Invest"},{"issue":"8","key":"2019041121494138000_B168","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1359\/jbmr.2000.15.8.1440","article-title":"Developmental expression and tissue distribution of Phex protein: effect of the Hyp mutation and relationship to bone markers","volume":"15","author":"Ruchon","year":"2000","journal-title":"J Bone Miner Res"},{"issue":"1","key":"2019041121494138000_B169","doi-asserted-by":"crossref","first-page":"E38","DOI":"10.1152\/ajpendo.00008.2006","article-title":"Pathogenic role of Fgf23 in Hyp mice","volume":"291","author":"Liu","year":"2006","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"8","key":"2019041121494138000_B170","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1096\/fj.10-177816","article-title":"Bone proteins PHEX and DMP1 regulate fibroblastic growth factor Fgf23 expression in osteocytes through a common pathway involving FGF receptor (FGFR) signaling","volume":"25","author":"Martin","year":"2011","journal-title":"FASEB J"},{"issue":"2","key":"2019041121494138000_B171","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/jbmr.544","article-title":"A Phex mutation in a murine model of X-linked hypophosphatemia alters phosphate responsiveness of bone cells","volume":"27","author":"Ichikawa","year":"2012","journal-title":"J Bone Miner Res"},{"issue":"1","key":"2019041121494138000_B172","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/jbmr.1738","article-title":"Hexa-D-arginine treatment increases 7B2\u2022PC2 activity in hyp-mouse osteoblasts and rescues the HYP phenotype","volume":"28","author":"Yuan","year":"2013","journal-title":"J Bone Miner Res"},{"issue":"1","key":"2019041121494138000_B173","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/er.2013-1009","article-title":"The rachitic tooth","volume":"35","author":"Foster","year":"2014","journal-title":"Endocr Rev"},{"issue":"10","key":"2019041121494138000_B174","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1210\/JC.2015-2199","article-title":"Conventional therapy in adults with X-linked hypophosphatemia: effects on enthesopathy and dental disease","volume":"100","author":"Connor","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2019041121494138000_B175","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/00007632-200103010-00029","article-title":"Ossification of the posterior longitudinal ligament in vitamin D-resistant rickets: case report and review of the literature","volume":"26","author":"Velan","year":"2001","journal-title":"Spine"},{"issue":"12","key":"2019041121494138000_B176","doi-asserted-by":"crossref","first-page":"5906","DOI":"10.1210\/en.2012-1551","article-title":"Mineralizing enthesopathy is a common feature of renal phosphate-wasting disorders attributed to FGF23 and is exacerbated by standard therapy in hyp mice","volume":"153","author":"Karaplis","year":"2012","journal-title":"Endocrinology"},{"issue":"4","key":"2019041121494138000_B177","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.bone.2011.06.029","article-title":"A patient with hypophosphatemic rickets and ossification of posterior longitudinal ligament caused by a novel homozygous mutation in ENPP1 gene","volume":"49","author":"Saito","year":"2011","journal-title":"Bone"},{"issue":"3","key":"2019041121494138000_B178","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00223-009-9270-6","article-title":"Survey of the enthesopathy of X-linked hypophosphatemia and its characterization in Hyp mice","volume":"85","author":"Liang","year":"2009","journal-title":"Calcif Tissue Int"},{"issue":"3","key":"2019041121494138000_B179","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s00223-009-9260-8","article-title":"Mutational analysis of the PHEX gene: novel point mutations and detection of large deletions by MLPA in patients with X-linked hypophosphatemic rickets","volume":"85","author":"Clausmeyer","year":"2009","journal-title":"Calcif Tissue Int"},{"issue":"8","key":"2019041121494138000_B180","doi-asserted-by":"crossref","first-page":"3840","DOI":"10.1210\/jcem.86.8.7730","article-title":"X-linked hypophosphatemia attributable to pseudoexons of the PHEX gene","volume":"86","author":"Christie","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2019041121494138000_B181","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1530\/EJE-12-0071","article-title":"Mutational analysis of patients with FGF23-related hypophosphatemic rickets","volume":"167","author":"Kinoshita","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2019041121494138000_B182","doi-asserted-by":"crossref","first-page":"R13","DOI":"10.1530\/EC-13-0103","article-title":"Therapeutic management of hypophosphatemic rickets from infancy to adulthood","volume":"3","author":"Linglart","year":"2014","journal-title":"Endocr Connect"},{"issue":"3","key":"2019041121494138000_B183","first-page":"879","article-title":"A prospective trial of phosphate and 1,25-dihydroxyvitamin D3 therapy in symptomatic adults with X-linked hypophosphatemic rickets","volume":"75","author":"Sullivan","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121494138000_B184","unstructured":"Shanbhogue VV , HansenS, J\u00f8rgensenNR, Beck-NielsenSS. Impact of conventional medical therapy on bone mineral density and bone turnover in adult patients with X-linked hypophosphatemia: a 6-year prospective cohort study [published online ahead of print November 15, 2017]. Calcif Tissue Int."},{"issue":"5","key":"2019041121494138000_B185","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1002\/jbmr.1838","article-title":"Cinacalcet as adjunctive therapy for hereditary 1,25-dihydroxyvitamin D-resistant rickets","volume":"28","author":"Srivastava","year":"2013","journal-title":"J Bone Miner Res"},{"issue":"3","key":"2019041121494138000_B186","doi-asserted-by":"crossref","first-page":"274","DOI":"10.14310\/horm.2002.1277","article-title":"Cinacalcet in hyperparathyroidism secondary to X-linked hypophosphatemic rickets: case report and brief literature review","volume":"9","author":"Yavropoulou","year":"2010","journal-title":"Hormones (Athens)"},{"issue":"10","key":"2019041121494138000_B187","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1002\/jbmr.478","article-title":"FGF receptors control vitamin D and phosphate homeostasis by mediating renal FGF-23 signaling and regulating FGF-23 expression in bone","volume":"26","author":"W\u00f6hrle","year":"2011","journal-title":"J Bone Miner Res"},{"issue":"3","key":"2019041121494138000_B188","doi-asserted-by":"crossref","first-page":"F217","DOI":"10.1152\/ajprenal.00332.2015","article-title":"The fibroblast growth factor receptor mediates the increased FGF23 expression in acute and chronic uremia","volume":"310","author":"Hassan","year":"2016","journal-title":"Am J Physiol Renal Physiol"},{"key":"2019041121494138000_B189","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jmgm.2017.04.024","article-title":"Targeted inhibition of Klotho binding to fibroblast growth factor 23 prevents hypophosphetemia","volume":"75","author":"Fakhar","year":"2017","journal-title":"J Mol Graph Model"},{"issue":"10","key":"2019041121494138000_B190","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1002\/jbmr.3197","article-title":"Therapeutic effects of FGF23 c-tail Fc in a murine preclinical model of X-linked hypophosphatemia via the selective modulation of phosphate reabsorption","volume":"32","author":"Johnson","year":"2017","journal-title":"J Bone Miner Res"},{"issue":"455","key":"2019041121494138000_B191","doi-asserted-by":"crossref","first-page":"ra113","DOI":"10.1126\/scisignal.aaf5034","article-title":"A computationally identified compound antagonizes excess FGF-23 signaling in renal tubules and a mouse model of hypophosphatemia","volume":"9","author":"Xiao","year":"2016","journal-title":"Sci Signal"},{"issue":"11","key":"2019041121494138000_B192","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1359\/jbmr.090509","article-title":"Therapeutic effects of anti-FGF23 antibodies in hypophosphatemic rickets\/osteomalacia","volume":"24","author":"Aono","year":"2009","journal-title":"J Bone Miner Res"},{"issue":"4","key":"2019041121494138000_B193","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/jbmr.275","article-title":"Anti-FGF-23 neutralizing antibodies ameliorate muscle weakness and decreased spontaneous movement of Hyp mice","volume":"26","author":"Aono","year":"2011","journal-title":"J Bone Miner Res"},{"issue":"9","key":"2019041121494138000_B194","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1359\/jbmr.080417","article-title":"Anti-FGF23 neutralizing antibodies show the physiological role and structural features of FGF23","volume":"23","author":"Yamazaki","year":"2008","journal-title":"J Bone Miner Res"},{"key":"2019041121494138000_B195","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.bonr.2016.05.004","article-title":"Effect of four monthly doses of a human monoclonal anti-FGF23 antibody (KRN23) on quality of life in X-linked hypophosphatemia","volume":"5","author":"Ruppe","year":"2016","journal-title":"Bone Rep"},{"issue":"4","key":"2019041121494138000_B196","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/path.4465","article-title":"Identification of a novel FN1-FGFR1 genetic fusion as a frequent event in phosphaturic mesenchymal tumour","volume":"235","author":"Lee","year":"2015","journal-title":"J Pathol"},{"issue":"11","key":"2019041121494138000_B197","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/modpathol.2016.137","article-title":"Characterization of FN1-FGFR1 and novel FN1-FGF1 fusion genes in a large series of phosphaturic mesenchymal tumors","volume":"29","author":"Lee","year":"2016","journal-title":"Mod Pathol"}],"container-title":["Endocrine Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/edrv\/article-pdf\/39\/3\/274\/25006934\/er.2017-00220.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T08:31:01Z","timestamp":1660379461000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/edrv\/article\/39\/3\/274\/4825438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,26]]},"references-count":197,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,1,26]]},"published-print":{"date-parts":[[2018,6,1]]}},"URL":"https:\/\/doi.org\/10.1210\/er.2017-00220","relation":{},"ISSN":["0163-769X","1945-7189"],"issn-type":[{"value":"0163-769X","type":"print"},{"value":"1945-7189","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,6]]},"published":{"date-parts":[[2018,1,26]]}}}